FDA Alert
FDA Alert
07/24/2023
Jessica Ganga
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
07/24/2023
FDA Alert
FDA Alert
06/15/2023
Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
FDA ALERT
FDA ALERT
04/18/2023
Jessica Ganga
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
04/18/2023
Enzyme Replacement Therapy
Enzyme Replacement Therapy
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
Treatment
Treatment
08/23/2022
The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.
08/23/2022
Pediatrics
Pediatrics
04/07/2021
The US Food and Drug Administration has approved a new nonstimulant drug for the treatment for attention-deficit/hyperactivity disorder in children.
04/07/2021
Pediatrics
Pediatrics
06/17/2020
The US Food and Drug Administration has approved the marketing of the first video game-based digital therapeutic device for the treatment of children aged 8 to 12 years with attention deficit hyperactivity...
06/17/2020
smoking
smoking
01/03/2020
The Food and Drug Administration (FDA) has issued an enforcement policy on the manufacturing and distribution of unauthorized flavored e-cigarette products that appeal to children.
01/03/2020
peanut allergy
peanut allergy
09/16/2019
An FDA advisory committee has recommended the approval of the first therapy for peanut allergies.
09/16/2019
FDA
FDA
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017